Wutah dodolan YoY sajrone 12 wulan kepungkur: pdsbiotech.com (PDSB)

PDS Biotechnology is optimizing production through CDMO partners to minimize downtime. The GURU.Markets system provides the sales volume change metric relative to the previous year (TTM), where 0.00 expresses the latest level of this metric. The development of the Versamune ecosystem to combat metastases and the scaling of Phase II/III clinical programs with the support of US oncology centers confirm the company's strategic growth potential.
PDS Biotechnology (PDSB) - rincian metrik lan laporan keuangan

Vaccine development automation via the Versamune platform and AI optimizes costs for PDS Biotechnology, enhancing operational efficiency. This 12-month year-over-year revenue growth rate captures sales dynamics by comparing a rolling annual period with the same interval from the previous year. This methodology neutralizes seasonality, revealing the true fundamental resilience of the business. Analyzing this metric allows for the filtering of market noise and an assessment of the model's scalability. Study this chart to determine the long-term growth trend.